- Palabras clave > antibacterial resistance (ABR)
- Palabras clave > antibiotic resistance
- Palabras clave > antimicrobial resistance (AMR)
- Palabras clave > antimicrobial resistance surveillance
- Palabras clave > containing drug resistance - coalition-based approach
- Palabras clave > containment of antimicrobial resistance
- Palabras clave > drug resistance, microbial
- Palabras clave > new medicines
- Palabras clave > pharmaceutical research and development (R&D)
- Palabras clave > surveillance - antibiotic resistance and antibiotic use
- Palabras clave > confinement antimicrobien
(2017; 10 pages)
Antimicrobial resistance (AMR) is one of the world’s most pressing and urgent global health threats—one that could erode gains against tuberculosis (TB), malaria, HIV/AIDS, and many other infectious diseases. AMR poses an enormous threat to the safety and feasibility of complex surgeries and procedures like organ transplantation and chemotherapy and can make childbirth, minor infections, and hospital stays more perilous. While AMR has emerged as a critical issue at the global level, current efforts to address AMR are insufficient to curb its spread. Immediate, cross-cutting, and multidisciplinary action is required to adequately address the multidimensional drivers of AMR. In the health sector, strengthening the systems through which health services and medicines are provided is a prerequisite to making progress against AMR.
This technical brief discusses how the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program, funded by the US Agency for International Development (USAID), is working to address AMR through a health system strengthening approach with interventions spanning the global, regional, national, and local levels.